Clinical trials
Completed Phase 2 Gliosarcoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
129 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 7 |
| 2001 | 10 |
| 2002 | 6 |
| 2003 | 4 |
| 2004 | 6 |
| 2005 | 9 |
| 2006 | 10 |
| 2007 | 15 |
| 2008 | 10 |
| 2009 | 10 |
| 2010 | 6 |
| 2011 | 4 |
| 2012 | 4 |
| 2013 | 3 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2021 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 129 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 25 |
| Duke University | 19 |
| European Organisation for Research and Treatment of Cancer - EORTC | 7 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 7 |
| Memorial Sloan Kettering Cancer Center | 4 |
| Radiation Therapy Oncology Group | 4 |
| University of California, San Francisco | 4 |
| Alliance for Clinical Trials in Oncology | 3 |
| Dana-Farber Cancer Institute | 3 |
| Jonsson Comprehensive Cancer Center | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Glioblastoma | 129 |
| Gliosarcoma | 129 |
| Brain Neoplasms | 81 |
| Central Nervous System Neoplasms | 65 |
| Glioma | 47 |
| Astrocytoma | 46 |
| Oligodendroglioma | 35 |
| Ependymoma | 11 |
| Glioma, Subependymal | 10 |
| Medulloblastoma | 6 |
Trials
Showing 1 to 25 of 129. Each trial links to its page on Pharma Observatory.
29 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.